Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

REVIEW-ARTICLE Intermediate alleles of Huntington's disease HTT gene in different populations worldwide: a systematic review.

Apolinário TA, Paiva CL, Agostinho LA.

Genet Mol Res. 2017 Apr 5;16(2). doi: 10.4238/gmr16029648. Review.

PMID:
28387881
2.

Deutetrabenazine: Treatment of hyperkinetic aspects of Huntington's disease, tardive dyskinesia and Tourette syndrome.

Paton DM.

Drugs Today (Barc). 2017 Feb;53(2):89-102. doi: 10.1358/dot.2017.53.2.2589164. Review.

PMID:
28387387
3.

Protective Effect of Antioxidants on Neuronal Dysfunction and Plasticity in Huntington's Disease.

Velusamy T, Panneerselvam AS, Purushottam M, Anusuyadevi M, Pal PK, Jain S, Essa MM, Guillemin GJ, Kandasamy M.

Oxid Med Cell Longev. 2017;2017:3279061. doi: 10.1155/2017/3279061. Epub 2017 Jan 12. Review.

4.

The Role of Reactive Oxygen Species in the Pathogenesis of Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease: A Mini Review.

Manoharan S, Guillemin GJ, Abiramasundari RS, Essa MM, Akbar M, Akbar MD.

Oxid Med Cell Longev. 2016;2016:8590578. doi: 10.1155/2016/8590578. Epub 2016 Dec 27. Review.

5.

Current Pharmacological Approaches to Reduce Chorea in Huntington's Disease.

Coppen EM, Roos RA.

Drugs. 2017 Jan;77(1):29-46. doi: 10.1007/s40265-016-0670-4. Review.

6.

DNA repair in the trinucleotide repeat disorders.

Jones L, Houlden H, Tabrizi SJ.

Lancet Neurol. 2017 Jan;16(1):88-96. doi: 10.1016/S1474-4422(16)30350-7. Review.

PMID:
27979358
7.

Investigational agents for the management of Huntington's disease.

Müller T.

Expert Opin Investig Drugs. 2017 Feb;26(2):175-185. doi: 10.1080/13543784.2017.1270266. Epub 2016 Dec 16. Review.

PMID:
27927041
8.

A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease.

McGarry A, McDermott M, Kieburtz K, de Blieck EA, Beal F, Marder K, Ross C, Shoulson I, Gilbert P, Mallonee WM, Guttman M, Wojcieszek J, Kumar R, LeDoux MS, Jenkins M, Rosas HD, Nance M, Biglan K, Como P, Dubinsky RM, Shannon KM, O'Suilleabhain P, Chou K, Walker F, Martin W, Wheelock VL, McCusker E, Jankovic J, Singer C, Sanchez-Ramos J, Scott B, Suchowersky O, Factor SA, Higgins DS Jr, Molho E, Revilla F, Caviness JN, Friedman JH, Perlmutter JS, Feigin A, Anderson K, Rodriguez R, McFarland NR, Margolis RL, Farbman ES, Raymond LA, Suski V, Kostyk S, Colcher A, Seeberger L, Epping E, Esmail S, Diaz N, Fung WL, Diamond A, Frank S, Hanna P, Hermanowicz N, Dure LS, Cudkowicz M; Huntington Study Group 2CARE Investigators and Coordinators.

Neurology. 2017 Jan 10;88(2):152-159. doi: 10.1212/WNL.0000000000003478. Epub 2016 Dec 2.

PMID:
27913695
9.

AMPK in Neurodegenerative Diseases.

Domise M, Vingtdeux V.

EXS. 2016;107:153-177. Review.

PMID:
27812980
10.

Energy defects in Huntington's disease: Why "in vivo" evidence matters.

Liot G, Valette J, Pépin J, Flament J, Brouillet E.

Biochem Biophys Res Commun. 2017 Feb 19;483(4):1084-1095. doi: 10.1016/j.bbrc.2016.09.065. Epub 2016 Sep 14. Review.

PMID:
27639641
11.

Possible role of mitochondrial permeability transition pore in the pathogenesis of Huntington disease.

Quintanilla RA, Tapia C, Pérez MJ.

Biochem Biophys Res Commun. 2017 Feb 19;483(4):1078-1083. doi: 10.1016/j.bbrc.2016.09.054. Epub 2016 Sep 13. Review.

PMID:
27638306
12.

Neuroimmunology of Huntington's Disease: Revisiting Evidence from Human Studies.

Rocha NP, Ribeiro FM, Furr-Stimming E, Teixeira AL.

Mediators Inflamm. 2016;2016:8653132. doi: 10.1155/2016/8653132. Epub 2016 Aug 8. Review.

13.

Guidelines for clinical pharmacological practices in Huntington's disease.

Désaméricq G, Youssov K, Charles P, Saleh N, Olivier A, Sherer-Gagou C, Verny C; multidisciplinary working group, Bachoud-Lévi AC.

Rev Neurol (Paris). 2016 Aug - Sep;172(8-9):423-432. doi: 10.1016/j.neurol.2016.07.012. Epub 2016 Aug 22. Review.

PMID:
27561440
14.

Mitochondrial fragmentation in neuronal degeneration: Toward an understanding of HD striatal susceptibility.

Cherubini M, Ginés S.

Biochem Biophys Res Commun. 2017 Feb 19;483(4):1063-1068. doi: 10.1016/j.bbrc.2016.08.042. Epub 2016 Aug 8. Review.

PMID:
27514446
15.

Mitochondrial Ca2+ handling in Huntington's and Alzheimer's diseases - Role of ER-mitochondria crosstalk.

Naia L, Ferreira IL, Ferreiro E, Rego AC.

Biochem Biophys Res Commun. 2017 Feb 19;483(4):1069-1077. doi: 10.1016/j.bbrc.2016.07.122. Epub 2016 Jul 30. Review.

PMID:
27485547
16.

Music therapy in Huntington's disease: a protocol for a multi-center randomized controlled trial.

van Bruggen-Rufi M, Vink A, Achterberg W, Roos R.

BMC Psychol. 2016 Jul 26;4(1):38. doi: 10.1186/s40359-016-0146-z.

17.

Striatal synaptic dysfunction and altered calcium regulation in Huntington disease.

Raymond LA.

Biochem Biophys Res Commun. 2017 Feb 19;483(4):1051-1062. doi: 10.1016/j.bbrc.2016.07.058. Epub 2016 Jul 14. Review.

PMID:
27423394
18.

Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.

Huntington Study Group, Frank S, Testa CM, Stamler D, Kayson E, Davis C, Edmondson MC, Kinel S, Leavitt B, Oakes D, O'Neill C, Vaughan C, Goldstein J, Herzog M, Snively V, Whaley J, Wong C, Suter G, Jankovic J, Jimenez-Shahed J, Hunter C, Claassen DO, Roman OC, Sung V, Smith J, Janicki S, Clouse R, Saint-Hilaire M, Hohler A, Turpin D, James RC, Rodriguez R, Rizer K, Anderson KE, Heller H, Carlson A, Criswell S, Racette BA, Revilla FJ, Nucifora F Jr, Margolis RL, Ong M, Mendis T, Mendis N, Singer C, Quesada M, Paulsen JS, Brashers-Krug T, Miller A, Kerr J, Dubinsky RM, Gray C, Factor SA, Sperin E, Molho E, Eglow M, Evans S, Kumar R, Reeves C, Samii A, Chouinard S, Beland M, Scott BL, Hickey PT, Esmail S, Fung WL, Gibbons C, Qi L, Colcher A, Hackmyer C, McGarry A, Klos K, Gudesblatt M, Fafard L, Graffitti L, Schneider DP, Dhall R, Wojcieszek JM, LaFaver K, Duker A, Neefus E, Wilson-Perez H, Shprecher D, Wall P, Blindauer KA, Wheeler L, Boyd JT, Houston E, Farbman ES, Agarwal P, Eberly SW, Watts A, Tariot PN, Feigin A, Evans S, Beck C, Orme C, Edicola J, Christopher E.

JAMA. 2016 Jul 5;316(1):40-50. doi: 10.1001/jama.2016.8655.

PMID:
27380342

Supplemental Content

Loading ...
Support Center